新闻/Reuters/Immutep’S Efti With Radiotherapy & KEYTRUDA® Meets Primary Endpoint In Phase 2 For Soft Tissue SarcomaImmutep’S Efti With Radiotherapy & KEYTRUDA® Meets Primary Endpoint In Phase 2 For Soft Tissue SarcomaRefinitiv阅读少于1分钟IMMImmutep Ltd IMM:IMMUTEP’S EFTI WITH RADIOTHERAPY & KEYTRUDA® (PEMBROLIZUMAB) MEETS PRIMARY ENDPOINT IN PHASE II FOR SOFT TISSUE SARCOMAReuters大洋洲澳大利亚股票美国股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
